AstraZeneca hands global oncology portfolio to Edelman
Edelman has picked up a lucrative account with AstraZeneca to handle its entire global oncology portfolio.

Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>